Response to Infliximab After Loss of Response to Adalimumab in Crohn’s Disease.

Response to Infliximab After Loss of Response to Adalimumab in Crohn’s Disease.

Inflamm Bowel Dis. 2019 Nov 21;:

Authors: Bauer CM, Younis A, Herfarth H, Barnes EL

PMID: 31750909 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31750909?dopt=Abstract